Group One Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,939
| Closed | -$479K | – | 5943 |
|
|
2019
Q3 | $479K | Sell |
4,939
-60,469
| -92% | -$6.05M | ﹤0.01% | 2373 |
|
|
2019
Q2 | $6.7M | Buy |
+65,408
| New | +$7.06M | 0.06% | 390 |
|
|
2019
Q1 | – | Sell |
-30,838
| Closed | -$2.27M | – | 5691 |
|
|
2018
Q4 | $1.21M | Buy |
+30,838
| New | +$1.34M | 0.01% | 1367 |
|
|
2018
Q1 | – | Sell |
-116,321
| Closed | -$6.72M | – | 5572 |
|
|
2017
Q4 | $5.98M | Buy |
+116,321
| New | +$8.36M | 0.04% | 545 |
|
|
2017
Q3 | – | Sell |
-9,254
| Closed | -$703K | – | 5386 |
|
|
2017
Q2 | $553K | Buy |
9,254
+8,318
| +889% | +$465K | 0.01% | 1905 |
|
|
2017
Q1 | $50K | Buy |
+936
| New | +$55.6K | ﹤0.01% | 3409 |
|
|
2016
Q4 | – | Sell |
-1,649
| Closed | -$88.3K | – | 5057 |
|
|
2016
Q3 | $99K | Buy |
+1,649
| New | +$95.1K | ﹤0.01% | 2931 |
|
|
2016
Q2 | – | Sell |
-2,682
| Closed | -$115K | – | 5113 |
|
|
2016
Q1 | $79K | Buy |
2,682
+396
| +17% | +$12.5K | ﹤0.01% | 2988 |
|
|
2015
Q4 | $104K | Buy |
+2,286
| New | +$120K | ﹤0.01% | 2950 |
|
|
2015
Q3 | – | Sell |
-8,665
| Closed | -$452K | – | 5401 |
|
|
2015
Q2 | $522K | Buy |
8,665
+5,822
| +205% | +$385K | 0.01% | 1747 |
|
|
2015
Q1 | $220K | Buy |
+2,843
| New | +$164K | ﹤0.01% | 2299 |
|
Group One Trading's ONCE Position: Q4 2019 in Review
Group One Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 4,939 shares — an estimated $479K sold.
Group One Trading first reported a position in ONCE in Q1 2015 and held it in 11 quarters. The position peaked at $6.7M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Group One Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Group One Trading sold 4,939 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $479K.
- Group One Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
- Group One Trading's Spark Therapeutics, Inc. Common Stock position peaked at $6.7M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Group One Trading's 13F filing for Q4 2019, filed 10 Feb 2020.